 CAMBRIDGE, Mass., March 18, 2021 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ:SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today reported financial results for the fourth quarter and full year ended December 31, 2020 as well as certain other business highlights. 